Actionable news
All posts from Actionable news
Actionable news in PFE: PFIZER Inc,

Pfizer near deal to buy cancer drug firm Medivation for almost $14 billion: Sources

Pfizer is in advanced talks to acquire U.S. cancer drug company Medivation for close to $14 billion, as it seeks to boost its oncology portfolio, people familiar with the matter said on Sunday.

Pfizer has agreed to pay a little more than $80 per share for Medivation, one of the people said, a substantial premium to the $52.50 offer for Medivation that France's Sanofi made in April, which eventually resulted in the company putting itself up for sale. Medivation shares ended trading in New York on Friday at $67.16.

Reuters reported earlier this week that Pfizer, Sanofi, Merck & Co, Celgene and Gilead Sciences had submitted expressions of interest to acquire Medivation.

The strong acquisition interest in the San Francisco-based company illustrates how...